Skip to content

Ap. Pharmamax

Active
Private limited company (pre-2019)founded 198838 years activePeter Benoitstraat 46, 2850 Boom, BelgiumKBO/BCE: BE 0434.458.941
Summary

Ap. Pharmamax has been active since 1988 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €350,028 and a net result of €290,195. Equity is growing by ~27.3% per year across the filed fiscal years. Its solvency ranks better than 48% of 12,411 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€1.0mtotal assets 2024
Staff
0.8 FTE
Equity
€350,028
Profit
€290,195
Turnover not published (abridged schema)
Financial health
89 Excellent Checked score 2024
Bankruptcy probability, 12 months
0.2%
Structure
Parent
Pharmagrex · 100%
Accounts 68 days overdue0 of 5 deeds read
Why 89- Latest accounts 60 days late; 3 of the last 3 late+ Liquidity: current ratio 1.46, cash €549,619+ Founded in 1988+ Size: total assets €1.1mShow the evidence

Checked score

Score 2024
89 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 63% of its sector peers (NACE 47, micro)
Financial strength · tick = 2023
Strong
Solvency 60-6
equity 34.7% of total assets
Liquidity 59-17
short-term debt 65.3% · cash 35.2%
Profitability 100=
return on assets 28.7%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,169 companies)
Last 24 months 11-2024: 0.5% 12-2024: 0.8%▲ +0.3 percentage points vs 11-2024highest value 01-2025: 0.3%▼ -0.5 percentage points vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.2%▼ -0.1 percentage points vs 05-2025 07-2025: 0.3%▲ +0.1 percentage points vs 06-2025 08-2025: 0.5%▲ +0.2 percentage points vs 07-2025 09-2025: 0.5%● unchanged vs 08-2025 10-2025: 0.1%▼ -0.4 percentage points vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026lowest value 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.2 percentage points vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.2%▼ -0.1 percentage points vs 09-2026
Credit up to €30,000 at 30 days acceptable
Liquidity tight (current ratio 1.44 against 1.88 in 2023; short-term debt: 65.3% and cash: 35.2% of total assets), and 65.3% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 50% on solvency, 66% on liquidity, 96% on profitability and 39% on growth.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
raises risk · Latest accounts 60 days late; 3 of the last 3 late
NBB · filings
lowers risk · Liquidity: current ratio 1.46, cash €549,619
NBB · annual accounts
lowers risk · Founded in 1988
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
lowers risk · Size: total assets €1.1m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 04-09-2025, 35 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
35 days late
2023
139 days late
2022
140 days late
2021
60 days late
2020
17 days late
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 65 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · abbreviated…
  2. Annual accounts filedfiscal year 2023 · abbreviated…
  3. Highest result since 2018net €323,030 ▲45.3%

Key points

  • Caution: Accounts not fileddeadline was 31-07-2026 68 days late View
  • Positive: Among the best 20% on net resultsector median €28,351 · 12,399 companies €130,718 View
  • Controlled by Pharmagrex 100% View
  • Positive: 7 profitable years in a rowprofit 2024: €290,195 7 years View

By topic

Financials

Fiscal year
2024
Total assets
€1.0m
Profit
€290,195
Solvency
34.7%
Total assets▲ 18.6%
Net result
20182024
Go to Financials

Timeline

Events
12
Since
2016
  1. 18-12-2023Annual accounts filed
  2. 31-12-2022Equity above €200,000
  3. 29-09-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
04-06-1988
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.